Testing frailty in people getting a left atrial appendage closure
Part of Heart & circulation clinical trials.
This study looks at frailty (how strong or vulnerable a person is) in adults who are having a left atrial appendage closure procedure through a catheter. The goal is to understand which patients may be more vulnerable during or after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- You are scheduled to have a catheter-based left atrial appendage closure using an approved device
- You can clearly understand the study and provide informed consent
- You do not have severe neuropsychiatric impairment (major problems with thinking, behavior, or mental functioning)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining a heart procedure (catheter ablation) with a device to close the left atrial appendage (LAAO) is safer or better than blood thinners alone for frail patients 75 years or older with atrial fibrillation and high stroke risk. It aims to find a treatment that reduces stroke while lowering bleeding risks.
This study looks at whether frailty (weakness and vulnerability) can help predict the risk of bleeding in older patients who have had a heart attack. The goal is to better identify who might need extra monitoring or different treatments to prevent dangerous bleeding.
This study compares two ways of closing a small pouch in the heart (the left atrial appendage) to help prevent strokes in people with atrial fibrillation (an irregular heartbeat). One method is less invasive, and the study aims to see if it is as safe and effective as the standard approach.
This study looks at how different imaging tests can help guide a procedure that closes off the left atrial appendage to reduce stroke risk. It may help doctors choose the safest approach during the procedure.
This trial tests a new device, the Append System, to close off the left atrial appendage (a small pouch in the heart) in people with atrial fibrillation. The goal is to reduce stroke risk without needing long-term blood thinners.
This study is testing a device called LAMBRE that is used to close a small pocket in the heart (the left atrial appendage). The goal is to see how well it works in everyday medical practice for people who need this closure procedure.
Hear when a new Frailty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.